U.S. Markets closed

Zacks Market Edge Highlights: UnitedHealth, Centene, MasTec, Bank of America and Bristol-Myers Squibb

Zacks Equity Research

For Immediate Release

Chicago, IL – September 12, 2019 – Zacks Market Edge is a podcast hosted weekly by cks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:

(Please add the Soundcloud link from this URL for the PR. Thanks: https://www.zacks.com/stock/news/513397/could-the-trade-war-be-bullish-for-stocks)

Could the Trade War Be Bullish for Stocks?

Welcome to Episode #193 of the Zacks Market Edge Podcast.

Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.

This week, Tracey is joined by John Blank, Zacks Chief Equity Strategist, to talk about the trade war and the economy.

Where could stocks go from here? Where should investors be parking their money?

Gold? Bitcoin? Value stocks?

3 Parts to the Trade War

1.       The intellectual property issues: trademarks, patents, branding etc. The FBI has said there are a thousand cases of theft from China. The two sides need to sit down and figure out improvement.

2.       The trade deficit is about $500 billion. If the US has a $21 trillion economy, that’s about 4% of the US economy.

3.       Must bring down the US deficit.

The Stock Market’s Response

Even with the tariffs and the trade issues as overhang, for the past 18 months, the stock market has been essentially flat. It hasn’t gone up, or down.

Is the pessimism already baked in?

Stocks to Hide Out In

1.       UnitedHealth Group UNH is among the healthcare stocks that have been ignored in 2019. It has a forward P/E of just 15.5 yet it’s supposed to grow earnings by 15% in 2019 and 12.2% in 2020.

2.       Centene CNC is even cheaper than UNH. It has a P/E of just 10.5. But it too has great earnings growth with analysts expecting 25% in 2019 and another 12% in 2012. That gives it a PEG of 0.7 which indicates its both a growth and a value stock.

3.       MasTec MTZ is an infrastructure play in energy and utilities including wind farms and wireless networks. Shares have really popped in 2019, adding 60% year-to-date. But they’re still cheap at just 13x. Earnings are expected to jump 32% in 2019.

4.       Bank of America BAC is also cheap, with a forward P/E of 10. John isn’t a fan of the banks with the Fed cutting though. But investors will get a dividend yielding 2.5% for their patience.

5.       Bristol-Myers Squibb BMY is a Zacks Rank #1 (Strong Buy). The drug giant is also cheap with a forward P/E of just 11.2. Investors also get a dividend yielding 3.4%.

What else should you know about investing during this period of economic uncertainty?

Listen to this week’s podcast to find out.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 7 stocks to watch. The report is only available for a limited time.

See 7 breakthrough stocks now>>

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/performance

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.